Next Article in Journal
Establishment of a Homologous Silencing System with Intact-Plant Infiltration and Minimized Operation for Studying Gene Function in Herbaceous Peonies
Previous Article in Journal
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Previous Article in Special Issue
Inferring Drug Set and Identifying the Mechanism of Drugs for PC3
 
 
Article
Peer-Review Record

Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria

Int. J. Mol. Sci. 2024, 25(8), 4410; https://doi.org/10.3390/ijms25084410
by Carla Di Chio 1,†, Josè Starvaggi 1,†, Noemi Totaro 1, Santo Previti 1, Benito Natale 2, Sandro Cosconati 2, Marta Bogacz 3, Tanja Schirmeister 4, Jenny Legac 5, Philip J. Rosenthal 5, Maria Zappalà 1 and Roberta Ettari 1,*
Reviewer 1: Anonymous
Int. J. Mol. Sci. 2024, 25(8), 4410; https://doi.org/10.3390/ijms25084410
Submission received: 22 March 2024 / Revised: 10 April 2024 / Accepted: 14 April 2024 / Published: 17 April 2024
(This article belongs to the Special Issue Molecular Advances in Computational Medicine and Drug Design)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

See attached

Comments for author File: Comments.pdf

Comments on the Quality of English Language


Author Response

Attached

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The manuscript ijms-2953199 reports the design, synthesis, and biological evaluation of novel heterocyclic compounds. The manuscript is well written, and I recommend the publication after major revisions as follows below:

1) Provide as Supplementary Material all spectra used to determine the chemical structure of the synthetic compounds.

2) In the Supplementary Material provide the method used to determine the purity of the compounds used in the biological assays. Do the authors used NMR with a standard compound to determine the purity percentage or other method? Please, explain it in the materials and methods section.

3) Please, provide the melting point values for the synthetic compounds (section 3.1.).

4) Please, provide the mass spectra of the synthetic compounds as Supplementary Materials and the corresponding signals in the section 3.1.

5) Molecular dynamics simulation must be carried out at least in triplicate to verify the consistency and reproducibility of the simulation and trend. Please, do it and compare the triplicate with the plots of RMSD and RMSF.

6) Provide the positive controls of the antitrypanosomal assays.

7) The authors claimed the use of the positive control E64 in the FP-2 inhibition assays, however, where is the plot and value?

 

8) What is the reason that in Figure 2 the authors only provided the antitrypanosomal activity of compound 2b and not all the assayed compounds? Please, provide the antitrypanosomal plots for the compounds 1a, 2a, 3a, and 6b. This is important to verify the potency and efficacy.

Author Response

Attached

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The authors of the manuscript ijms-2953199 replied to the Reviewers’ questions and improved the quality of the work. Thus, I recommend the publication of this work.

Back to TopTop